Literature DB >> 8352303

Lateral geniculate nucleus in glaucoma.

N Chaturvedi1, E T Hedley-Whyte, E B Dreyer.   

Abstract

To assess glaucomatous damage to the lateral geniculate nucleus of the thalamus, as well as to its magnocellular and parvocellular layers, we examined the autopsy sections of the lateral geniculate nucleus of individuals with and without glaucoma. Five patients with a documented history of glaucoma and five controls with no ophthalmic or chronic central nervous system disease were included in this study. Neurons were counted in autopsy sections of the lateral geniculate nucleus. Cells were counted in 40 random microscopic fields of the magnocellular and parvocellular layers respectively. The mean magnocellular cell density for the glaucoma group of 2.72 +/- 0.13 cells per square millimeter (mean +/- SEM) was significantly less than that for the control group of 3.76 +/- 0.13 cells per square millimeter (P < .001). There was no statistical difference in the parvocellular layer. These data suggest that glaucoma leads to greater loss of magnocellular tissue at the level of the lateral geniculate.

Entities:  

Mesh:

Year:  1993        PMID: 8352303     DOI: 10.1016/s0002-9394(14)71283-8

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  39 in total

1.  Retinal ganglion cell death in experimental glaucoma.

Authors:  J E Morgan; H Uchida; J Caprioli
Journal:  Br J Ophthalmol       Date:  2000-03       Impact factor: 4.638

2.  A comparison of perimetric results with the Medmont and Humphrey perimeters.

Authors:  J Landers; A Sharma; I Goldberg; S Graham
Journal:  Br J Ophthalmol       Date:  2003-06       Impact factor: 4.638

3.  Quantitative measurement of retinal ganglion cell populations via histology-based random forest classification.

Authors:  Adam Hedberg-Buenz; Mark A Christopher; Carly J Lewis; Kimberly A Fernandes; Laura M Dutca; Kai Wang; Todd E Scheetz; Michael D Abràmoff; Richard T Libby; Mona K Garvin; Michael G Anderson
Journal:  Exp Eye Res       Date:  2015-10-22       Impact factor: 3.467

4.  Electrophysiological assessment of glaucomatous visual dysfunction during treatment with cytidine-5'-diphosphocholine (citicoline): a study of 8 years of follow-up.

Authors:  Vincenzo Parisi
Journal:  Doc Ophthalmol       Date:  2005-01       Impact factor: 2.379

5.  How much is the brain involved in glaucoma?

Authors:  A Alm
Journal:  Br J Ophthalmol       Date:  2006-06       Impact factor: 4.638

6.  Treatment with citicoline eye drops enhances retinal function and neural conduction along the visual pathways in open angle glaucoma.

Authors:  Vincenzo Parisi; Marco Centofanti; Lucia Ziccardi; Lucia Tanga; Manuele Michelessi; Gloria Roberti; Gianluca Manni
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-05-26       Impact factor: 3.117

7.  Neural conduction in the visual pathways in ocular hypertension and glaucoma.

Authors:  V Parisi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-03       Impact factor: 3.117

8.  Ischemic model of optic nerve injury.

Authors:  George A Cioffi
Journal:  Trans Am Ophthalmol Soc       Date:  2005

Review 9.  Effects of optic nerve injury, glaucoma, and neuroprotection on the survival, structure, and function of ganglion cells in the mammalian retina.

Authors:  A J Weber; C D Harman; S Viswanathan
Journal:  J Physiol       Date:  2008-06-19       Impact factor: 5.182

10.  Astrocyte and microglial activation in the lateral geniculate nucleus and visual cortex of glaucomatous and optic nerve transected primates.

Authors:  Dawn Lam; Janey Jim; Eleanor To; Carol Rasmussen; Paul L Kaufman; Joanne Matsubara
Journal:  Mol Vis       Date:  2009-10-31       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.